UP!

HERO $20.64

HERO target price
20.64
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-03-28 Lower Price Target Wunderlich Buy $13.00 to $11.00
2016-03-28 Downgrade Global Hunter Securities Neutral to Reduce $0.70 to $0.60
2016-03-28 Lower Price Target Cowen and Company Outperform to Outperform $9.50 to $9.00
2016-03-28 Downgrade Seaport Global Securities Neutral to Reduce $0.70 to $0.60
2016-01-19 Lower Price Target Deutsche Bank Hold $7.00 to $6.00
2016-01-19 Lower Price Target Deutsche Bank AG Hold $7.00 to $6.00
2015-11-12 Reiterated Rating Seaport Global Securities Neutral
2015-11-10 Upgrade Deutsche Bank Sell to Hold $7.00
2015-06-22 Downgrade Johnson Rice Accumulate to Hold
2015-06-18 Reiterated Rating Deutsche Bank Sell
2015-06-18 Downgrade Simmons Neutral to Underweight
2015-06-05 Reiterated Rating Global Hunter Securities Reduce $0.70 to $0.60
2015-06-05 Reiterated Rating Cowen and Company Market Perform $0.50
2015-06-05 Reiterated Rating Seaport Global Securities Reduce $0.70 to $0.60
2015-05-26 Reiterated Rating Jefferies Group Hold
2015-04-30 Reiterated Rating Jefferies Group Hold
2015-02-27 Downgrade Deutsche Bank Buy to Sell
2015-02-13 Downgrade Howard Weil Sector Outperform to Sector Perform $3.00 to $1.00
2015-01-23 Downgrade Raymond James Market Perform to Underperform
2015-01-23 Downgrade Raymond James Financial Inc. Market Perform to Underperform
2015-01-08 Lower Price Target Jefferies Group Hold $1.50 to $0.75
2014-12-23 Downgrade Global Hunter Securities Neutral to Reduce $0.90 to $0.80
2014-12-23 Downgrade Seaport Global Securities Neutral to Reduce $0.90 to $0.80
2014-12-09 Downgrade Macquarie Neutral to Underperform
2014-12-03 Downgrade Stephens Overweight to Equal Weight
2014-12-03 Initiated Coverage Jefferies Group Hold $1.50
2014-10-28 Downgrade Macquarie Outperform to Neutral $4.50 to $2.00
2014-10-24 Reiterated Cowen Market Perform $2 to $1.50
2014-10-24 Lower Price Target Cowen and Company Market Perform $2.00 to $1.50
2014-10-17 Downgrade Cowen and Company Outperform to Market Perform $2.00 to $1.50
2014-10-15 Reiterated Rating Deutsche Bank Buy $6.00 to $4.00
2014-10-15 Initiated Coverage Evercore ISI Sell
2014-09-24 Reiterated Rating Wells Fargo & Co. Market Perform
2014-09-24 Reiterated Rating Wells Fargo Market Perform
2014-09-18 Reiterated Cowen Outperform $6 to $4
2014-09-18 Lower Price Target Cowen and Company Outperform $6.00 to $4.00
2014-08-05 Boost Price Target Global Hunter Securities $0.75 to $3.75
2014-08-05 Boost Price Target Seaport Global Securities $0.75 to $3.75
2014-07-24 Reiterated Rating Deutsche Bank Buy $7.00 to $6.00
2014-07-24 Reiterated Rating Jefferies Group Hold $5.00 to $4.50
2014-07-24 Lower Price Target Howard Weil Sector Outperform $8.00 to $5.50
2014-07-10 Boost Price Target Goldman Sachs $3.60 to $3.85
2014-07-10 Boost Price Target Goldman Sachs Group Inc. $3.60 to $3.85
2014-06-20 Downgrade Iberia Capital Outperform to Sector Perform
2014-06-20 Lower Price Target Cowen and Company Outperform $7.00 to $6.50
2014-06-04 Initiated Coverage Macquarie Outperform $6.00
2014-06-03 Reiterated Rating Johnson Rice Overweight
2014-04-24 Lower Price Target Howard Weil Sector Outperform $11.00 to $8.00
2014-04-24 Reiterated Rating Jefferies Group Hold $5.00
2014-03-25 Downgrade Credit Suisse Neutral $7.00 to $5.00
2014-02-11 Reiterated Cowen Outperform $9 to $7
2014-02-11 Lower Price Target Cowen and Company Outperform $9.00 to $7.00
2014-02-07 Lower Price Target Guggenheim $5.45 to $5.00
2014-01-29 Downgrade Simmons Overweight to Neutral
2014-01-24 Downgrade Wells Fargo & Co. Outperform to Market Perform
2014-01-24 Reiterated Rating Guggenheim Neutral $6.90 to $5.45
2014-01-24 Downgrade Wells Fargo Outperform to Market Perform
2014-01-23 Downgrade Global Hunter Securities Buy to Neutral $12.00 to $6.00
2014-01-23 Lower Price Target Wunderlich Buy $13.00 to $11.00
2014-01-22 Downgrade Tudor Pickering Buy to Accumulate
2014-01-13 Downgrade Evercore ISI Strong-Buy to Neutral
2013-09-19 Initiated Coverage Deutsche Bank Buy
2013-06-26 Reiterated FBR Capital Mkt Perform $7.70 to $8.20
2013-06-25 Reiterated Barclays Underweight $4 to $7
2013-02-13 Reiterated Howard Weil Sector Outperform $8 to $10
2013-02-13 Reiterated Dahlman Rose Buy $7.50 to $8.50
2012-12-20 Reiterated Dahlman Rose Buy $6.50 to $7.50
2012-10-26 Upgrade Dahlman Rose Hold to Buy $6.50
2012-05-02 Reiterated Dahlman Rose Hold $5 to $6
2011-11-07 Resumed Dahlman Rose Hold
2011-05-03 Upgrade FBR Capital Underperform to Outperform $8.50
2011-04-07 Upgrade Global Hunter Securities Neutral to Buy $5.30 to $7
2016-03-28 Lower Price Target Wunderlich Buy $13.00 to $11.00
2016-03-28 Downgrade Global Hunter Securities Neutral to Reduce $0.70 to $0.60
2016-03-28 Lower Price Target Cowen and Company Outperform to Outperform $9.50 to $9.00
2016-03-28 Downgrade Seaport Global Securities Neutral to Reduce $0.70 to $0.60
2016-01-19 Lower Price Target Deutsche Bank Hold $7.00 to $6.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Centerbridge Credit Partners, L.P. 1.17%  (1883554) BALT / HERO / MPO / STAY /
Rynd John T CEO & President 0.96%  (1546580) HERO / HOS / TDW /
Carson Troy L Chief Accounting Officer 0.33%  (536888) HERO /
Carr Terrell L Vice President-Worldwide Ops 0.33%  (528186) HERO /
Pellegrin Todd VP, Worldwide Liftboat Ops. 0.20%  (328291) HERO /
BATES THOMAS R JR 0.20%  (325000) HERO / ICD / TDW / TTI /
Butz Stephen M Sr. VP and CFO 0.19%  (308730) HERO / RDC /
Noe James William Sr. VP, Gen. Counsel, CCO 0.15%  (249127) HERO /
Thompson Beau M. General Counsel & Secretary 0.15%  (247228) HERO /
Feyling Claus President, Hercules Int\'l 0.11%  (184397) HERO /
Madonna Thomas J 0.08%  (125200) HERO /
AMONETT THOMAS N 0.06%  (96618) BRS / HERO / ORN /
BAER SUZANNE V 0.06%  (95771) HERO /
HAMILTON THOMAS M 0.06%  (94493) FTI / HCC / HERO /
PARKER F GARDNER 0.06%  (92100) CPT / CRZO / HERO / SMED / TPLM /
PILENKO THIERRY 0.05%  (82000) HERO / RDC /
Riddle Kimberly A Vice President, HR 0.04%  (61825) HERO /